works. Safety concerns will be reviewed during the study.
-- Lipo-Transfer: Kotaro Yoshimura, MD, a plastic surgeon from Tokyo, will
be presenting new advances in Lipo Transfer. One common problem with
this procedure is the difficulty predicting the survival rate of
transplanted fat or the risk of fibrosis and calcification. To overcome
the problem, Dr. Yoshimura has developed a strategy called Cell-Assisted
Lipotransfer (CAL), which employs patients' adipose-derived stem
cells and can be applied to breast augmentation. He expects that this
technique will improve the survival rate and prevent post operative
atrophy of transplanted fat tissue.
-- Laser-Assisted Lipolysis: Arturo Prado, MD, Barry E. DiBernardo, MD,
and Jeffrey M. Kenkel, MD, will present on laser-assisted (fat
destroying) Lipolysis. Dr. Prado, a plastic surgeon in Chile, will
report on his randomized double-blind study that compared traditional
lipoplasty and laser-assisted lipoplasty. Dr. DiBernardo (Cutera,
Cynosure, Lumensis and Apira Science), a plastic surgeon in Montclair,
NJ, is going to discuss the first preliminary clinical trial of
SmartLipo. Dr. Kenkel (Palomar), a plastic surgeon in Dallas, TX, will
discuss his clinical experience with CoolLipo and ProLipo.
As plastic surgeons concerned about patient safety, we want to be sure that the treatments we recommend are backed by good science and sufficient clinical experience," says Foad Nahai, MD, ASAPS President and a plastic surgeon in Atlanta, GA. "Many of these innovations in aesthetic surgery may prove to be widely beneficial, but at the beginning they must be used cautiously and, of course, only with the patient's full informed consent.
The American Society for Aesthetic Plastic Surgery (A
|SOURCE American Society for Aesthetic Plastic Surgery|
Copyright©2008 PR Newswire.
All rights reserved